Back to Trials
NCT06681129Recruiting

Study of Normal Intestinal Development and Disease in Premature and Term Neonates

Boston Children's Hospital

Start Date

3/17/2025

Completion Date

12/31/2034

Summary

Current research on early intestinal development is primarily performed in mouse models. While useful in many other ways, mouse models are not ideal for studying human intestine development as the timing of this process differs between the two species. Further, prior research has demonstrated that some proteins and pathways that are critical in human development have no clear role in mice. This study aims to improve the overall understanding of critical aspects of intestinal development in humans. In addition, this study will investigate the impact of intestinal diseases that are found in the early stages of life such as necrotizing enterocolitis (NEC).

Eligibility Criteria

Age Range: No minimum to 2 years

Inclusion Criteria: * Any neonate or infant through 2 years of age having intestinal surgery or intestinal biopsies from an esophogastroduodenoscopy (EGD) or colonoscopy. Exclusion Criteria: * Children \> 2 years of age. * Infants 0-2 years old not undergoing GI surgery or intestinal scope with biopsy procedure.

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

NECNecrotizing EnterocolitisIntestinal DiseaseHuman Development

Locations

Boston Children's Hospital

Boston, Massachusetts 02115

United States